Search by Drug Name or NDC

NDC 50090-3002-00 Delzicol 400 mg/1 Details

Delzicol 400 mg/1

Delzicol is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is MESALAMINE.

MedlinePlus Drug Summary

Mesalamine is used to treat ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum) and also to maintain improvement of ulcerative colitis symptoms. Mesalamine is in a class of medications called anti-inflammatory agents. It works by stopping the body from producing a certain substance that may cause inflammation.

Related Packages: 50090-3002-00
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Mesalamine

Product Information

NDC	50090-3002
Product ID	50090-3002_e6cfba3f-de99-4188-b44f-2536550385ab
Associated GPIs	52500030006530
GCN Sequence Number	076143
GCN Sequence Number Description	mesalamine CAP(DRTAB) 400 MG ORAL
HIC3	D6F
HIC3 Description	DRUG TX-CHRONIC INFLAM. COLON DX,5-AMINOSALICYLAT
GCN	41428
HICL Sequence Number	001848
HICL Sequence Number Description	MESALAMINE
Brand/Generic	Generic
Proprietary Name	Delzicol
Proprietary Name Suffix	n/a
Non-Proprietary Name	mesalamine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE, DELAYED RELEASE
Route	ORAL
Active Ingredient Strength	400
Active Ingredient Units	mg/1
Substance Name	MESALAMINE
Labeler Name	A-S Medication Solutions
Pharmaceutical Class	Aminosalicylate [EPC], Aminosalicylic Acids [CS]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA204412
Listing Certified Through	2024-12-31

Package

NDC 50090-3002-00 (50090300200)

Pricing Information	N/A
NDC Package Code	50090-3002-0
Billing NDC	50090300200
Package	180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (50090-3002-0)
Marketing Start Date	2017-05-04
NDC Exclude Flag	N